Close Menu

University College London

The researchers aim to find rearrangements in the small amounts of DNA that leak out from the bone cancer into the bloodstream.

The goal of the project is two-fold: the exome sequencing portion of the study will look for genes that underlie the genesis of the disease, while whole-genome sequencing of patients' plasma will be used to look for patient-specific rearrangements that could be used as the basis for a test.

BD will use UCL's biobanks of more than 200,000 patient samples to develop and validate biomarker assays.

Based on findings from the Whitehall II prospective study, a team of University College London researchers concluded that two non-genetic risk models more accurately predicted type 2 diabetes risk than a genetic model based on 20 risk alleles.

CEO Jaakko Pellosniemi told BioArray News week that the recent study might be able to give Mobidiag traction in a market where it is competing against an established technology.

The $800 million facility in central London is expected to open in 2014-2015, and will aim to foster collaborative research efforts employing a variety of genomics-related tools.

Pfizer and UCL to develop stem-cell therapies for AMD; Clarient licenses breast cancer biomarkers from Indiana U; Nanosys and Harvard to outlicense nanowire IP; Luminex settles with SUNY and U of Illinois, and more …

Researchers in the Neuromuscular Disorder-Chip Consortium will use custom-designed NimbleGen Human CGH 12x135K microarrays and Human Sequence Capture 385K arrays to study the genetic underpinnings of a range of neuromuscular disorders.

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

Researchers from the Netherlands have uncovered a new gene expression signature linked to ovarian cancer survival that is providing hints about potential pathways of importance for the disease. But authors warn that using such signatures for guiding treatment may be a ways off.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.